Connection
Nickolas Zaller to Opiate Substitution Treatment
This is a "connection" page, showing publications Nickolas Zaller has written about Opiate Substitution Treatment.
|
|
Connection Strength |
|
 |
|
 |
|
1.456 |
|
|
|
-
Zaller N, Brinkley-Rubinstein L. MOUD Provision in Correctional Settings During Time of COVID-19: Prevention and Solutions. J Addict Med. 2020 12; 14(6):e290-e292.
Score: 0.682
-
Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, Noska A, Reddy M, Zaller N. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015 Jul 25; 386(9991):350-9.
Score: 0.465
-
Larney S, Zaller ND, Rich JD. HIV prevention, treatment, and care for people who inject drugs. J Infect Dis. 2013 Aug 01; 208(3):370-2.
Score: 0.100
-
Zaller N, McKenzie M, Friedmann PD, Green TC, McGowan S, Rich JD. Initiation of buprenorphine during incarceration and retention in treatment upon release. J Subst Abuse Treat. 2013 Aug; 45(2):222-6.
Score: 0.100
-
Taylor LE, Bowman SE, Chapman S, Zaller N, Stein MD, Cioe PA, Maynard MA, McGovern BH. Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug Alcohol Depend. 2011 Jul 01; 116(1-3):233-7.
Score: 0.086
-
McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, Rich JD. A randomized trial of methadone initiation prior to release from incarceration. Subst Abus. 2012; 33(1):19-29.
Score: 0.023
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|